Hesslein Robert W. has filed 8 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 757 shares of ALNYLAM PHARMACEUTICALS, INC. ($ALNY) on March 03, 2025.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Hesslein Robert W. | EVP, CLO and Secretary | A | Common Stock | 757 | $0.00 | 8,002.0000 | 127,651,000 | 10.45% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Hesslein Robert W. | EVP, CLO and Secretary | A | Stock Option (right to buy) | 1529 | $0.00 | 1,529.0000 | 127,651,000 | 9999.99% | 0.00% |
| Oct. 1, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Hesslein Robert W. | EVP, CLO and Secretary | A | Common Stock | 7245 | $0.00 | 7,245.0000 | 128,590,000 | 9999.99% | 0.01% |
| March 20, 2023 | Voyager Therapeutics, Inc. | $VYGR | Hesslein Robert W. | Senior VP & General Counsel | S | Common Stock | 4410 | $7.76 | 102,200.0000 | 38,356,810 | 4.14% | 0.01% |
| Feb. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Hesslein Robert W. | Senior VP & General Counsel | S | Common Stock | 3297 | $7.45 | 106,610.0000 | 38,356,810 | 3.00% | 0.01% |
| Feb. 13, 2023 | Voyager Therapeutics, Inc. | $VYGR | Hesslein Robert W. | Senior VP & General Counsel | S | Common Stock | 2868 | $7.67 | 109,907.0000 | 38,356,810 | 2.54% | 0.01% |
| Jan. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Hesslein Robert W. | Senior VP & General Counsel | S | Common Stock | 1396 | $9.57 | 113,567.0000 | 38,356,810 | 1.21% | 0.00% |
| Jan. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Hesslein Robert W. | Senior VP & General Counsel | S | Common Stock | 792 | $10.34 | 112,775.0000 | 38,356,810 | 0.70% | 0.00% |